Drug shortage
Methotrexate Injection · Assertio Specialty Pharmaceuticals, LLC
FDA drug shortage · To Be Discontinued · updated Aug 29, 2025
Key facts
| Generic name | Methotrexate Injection |
|---|---|
| Company | Assertio Specialty Pharmaceuticals, LLC |
| Presentation | Otrexup, Injection, 12.5 mg/.4 mL (NDC 82497-012-04) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Rheumatology |
| Package NDCs | 82497-012-04 |
| First posted | Aug 29, 2025 |
| Last updated | Aug 29, 2025 |
| Discontinued | Aug 29, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: